Neuralstem, Inc. Contracts & Agreements

Form of Employment Agreement with J.D. Finley, dated September 25, 2024 (Filed With SEC on September 27, 2024)

Amendment to Research Collaboration and License Agreement with Giiant Pharma, Inc. dated August 2, 2024 (Filed With SEC on August 12, 2024)

Form of Prefunded Warrant (Filed With SEC on May 3, 2024)

Form of Common Stock Warrant (Filed With SEC on May 3, 2024)

Form of Placement Agent Warrant (Filed With SEC on May 3, 2024)

Form of Securities Purchase Agreement (Filed With SEC on May 3, 2024)

Form of Registration Rights Agreement (Filed With SEC on May 3, 2024)

Form of Placement Agency Agreement (Filed With SEC on May 3, 2024)

Form of Replacement Warrant (Filed With SEC on February 1, 2024)

Form of Placement Agent Warrant (Filed With SEC on February 1, 2024)

Form of Warrant Inducement Agreement (Filed With SEC on February 1, 2024)

Form of Placement Agent Warrant (Filed With SEC on September 11, 2023)

Form of Securities Purchase Agreement (Filed With SEC on September 11, 2023)

Form of Placement Agency Agreement (Filed With SEC on September 11, 2023)

Form of Employment Agreement with Mitchell Jones, dated September 5, 2023 (Filed With SEC on September 11, 2023)

Form of Research Collaboration and License Agreement with Giiant Pharma (Filed With SEC on September 8, 2023)

Palisade Bio, Inc. 2021 Inducement Incentive Plan, as Amended August 7, 2023 (Filed With SEC on August 10, 2023)

Palisade 2021 Equity Incentive Plan, as amended (Filed With SEC on June 9, 2023)

Palisade 2021 Employee Stock Purchase Plan, as amended (Filed With SEC on June 9, 2023)

Form of Prefunded Warrant (Filed With SEC on April 5, 2023)

Form of Common Stock Warrant (Filed With SEC on April 5, 2023)

Form of Placement Agent Warrant (Filed With SEC on April 5, 2023)

Form of Securities Purchase Agreement (Filed With SEC on April 5, 2023)

Form of Registration Rights Agreement (Filed With SEC on April 5, 2023)

Form of Placement Agency Agreement (Filed With SEC on April 5, 2023)

Form of Registered Prefunded Warrant (Filed With SEC on January 4, 2023)

Form of Unregistered Prefunded Warrant (Filed With SEC on January 4, 2023)

Form of Common Stock Warrant (Filed With SEC on January 4, 2023)

Form of Placement Agent Warrant (Filed With SEC on January 4, 2023)

Form of Securities Purchase Agreement (Filed With SEC on January 4, 2023)

Form of Registration Rights Agreement (Filed With SEC on January 4, 2023)

Form of Placement Agent Agreement (Filed With SEC on January 4, 2023)

Form of Underwriter Warrant issued August 16, 2022 (Filed With SEC on November 14, 2022)

Separation Agreement and Release with former Chief Executive Officer (Filed With SEC on October 14, 2022)

Underwriting Agreement dated as of August 12, 2022, by and between Palisade bio, Inc. and Ladenburg Thalmann & Co. Inc (Filed With SEC on August 16, 2022)

Form of Series 1 Warrant (Filed With SEC on August 16, 2022)

Form of Series 2 Warrant (Filed With SEC on August 16, 2022)

Warrant Agency Agreement dated August 16, 2022, by and between Palisade Bio, Inc. and American Stock Transfer & Trust Company, LLC (Filed With SEC on August 16, 2022)

First Amendment dated July 14, 2022 to the Office Lease Between AP Beacon Carlsbad, LP, and Palisade Bio, Inc., dated May 12, 2022 (Filed With SEC on August 15, 2022)

Form of Underwriting Agreement (Filed With SEC on August 11, 2022)

Form of Warrant to Purchase Shares of Common Stock (Filed With SEC on August 11, 2022)

Form of Lock-Up and Voting Agreement (Filed With SEC on August 11, 2022)

Form of Leak-Out Agreement (Filed With SEC on August 11, 2022)

Form of Underwriting Agreement (Filed With SEC on August 10, 2022)

Form of Warrant to Purchase Shares of Common Stock (Filed With SEC on August 9, 2022)

Form of Warrant Agency Agreement (Filed With SEC on August 9, 2022)

Form of Series B Preferred Stock Certificate of Registrant (Filed With SEC on August 9, 2022)

Form of Leak-Out Agreement (Filed With SEC on August 9, 2022)

Form of Waiver and Right of Participation Letter Agreement (Filed With SEC on August 9, 2022)

Form of Underwriting Agreement (Filed With SEC on August 2, 2022)

Form of Warrant to Purchase Shares of Common Stock (Filed With SEC on August 2, 2022)

Form of Warrant Agency Agreement (Filed With SEC on August 2, 2022)

Form of Lock-Up and Voting Agreement (Filed With SEC on August 2, 2022)

Office Lease Between AP Beacon Carlsbad, LP, and Palisade Bio, Inc., dated May 12, 2022 (Filed With SEC on May 13, 2022)

Form of Common Stock Purchase Warrant (Filed With SEC on May 6, 2022)

Form of Securities Purchase Agreement, dated May 6, 2022, by and among the Company and the purchasers named therein (Filed With SEC on May 6, 2022)

Form of Placement Agent Warrant (Filed With SEC on May 6, 2022)

Placement Agency Agreement, dated May 6, 2022, by and between the Company and Ladenburg Thalmann & Co. Inc (Filed With SEC on May 6, 2022)

Description of Securities (Filed With SEC on March 17, 2022)

Specimen Common Stock Certificate (Filed With SEC on March 17, 2022)

License Agreement, by and between Palisade Bio, Inc. and The Regents of the University of California, dated July 6, 2021 (Filed With SEC on March 17, 2022)

Non-Employee Director Compensation Policy (Filed With SEC on March 17, 2022)

Asset Transfer Agreement, by and between Alto Neuroscience, Inc. and Palisade Bio, Inc., dated October 18, 2021 (Filed With SEC on March 17, 2022)

Waiver Agreement, dated as of January 31, 2022, by and between Palisade Bio, Inc. and Altium Growth Fund, LP (Filed With SEC on February 1, 2022)

Warrant, dated as of January 31, 2022, issued to Altium Growth Fund, LP (Filed With SEC on February 1, 2022)

Palisade Bio, Inc. 2021 Inducement Incentive Plan (Filed With SEC on November 23, 2021)

Form of Stock Option Grant Notice, Stock Option Agreement and Notice of Exercise under the Palisade Bio, Inc. 2021 Equity Incentive Plan (Filed With SEC on November 23, 2021)

Form of Non-Employee Director Stock Option Grant Notice, Stock Option Agreement and Notice of Exercise under the Palisade Bio, Inc. 2021 Equity Incentive Plan (Filed With SEC on November 23, 2021)

Palisade Bio, Inc. 2021 Equity Incentive Plan, as amended (Filed With SEC on November 23, 2021)

Securities Purchase Agreement, dated as of August 19, 2021, by and between Palisade Bio, Inc. and Yuma Regional Medical Center (Filed With SEC on August 24, 2021)

Warrant, dated as of August 19, 2021, issued to Yuma Regional Medical Center (Filed With SEC on August 24, 2021)

2021 Equity Incentive Plan (Filed With SEC on August 23, 2021)

2021 Employee Stock Purchase Plan (Filed With SEC on August 23, 2021)

Waiver Agreement, dated as of July 21, 2021, by and between Palisade Bio, Inc. and Altium Growth Fund, LP (Filed With SEC on July 22, 2021)

Warrant, dated as of July 21, 2021, issued to Altium Growth Fund, LP (Filed With SEC on July 22, 2021)

Amendment Agreement to Securities Purchase Agreement by and among, the Company, Leading BioSciences, Inc. and Altium Growth Fund, LP, dated May 3, 2021 (Filed With SEC on May 14, 2021)

Contingent Value Rights Agreement, dated as of April 27, 2021, by and among the Company, American Stock Transfer & Trust Company, LLC and Raul Silvestre (Filed With SEC on April 27, 2021)

Form of Separation Agreement (Filed With SEC on March 18, 2021)

Form of Warrant to Purchase Shares of Common Stock of Leading BioSciences, Inc (Filed With SEC on December 23, 2020)

Form of Senior Secured Note of Leading BioSciences, Inc (Filed With SEC on December 23, 2020)

License Agreement, by and between Leading BioSciences, Inc. and The Regents of the University of California, dated August 19, 2015, as amended on December 20, 2019 (Filed With SEC on December 23, 2020)

License Agreement, by and between Leading BioSciences, Inc. and The Regents of the University of California, dated April 1, 2020 (Filed With SEC on December 23, 2020)

Co-Development and Distribution Agreement, by and between Leading BioSciences, Inc. and Newsoara Biopharma Co., Ltd. (as successor-in-interest to Biolead Medical Technology... (Filed With SEC on December 23, 2020)

Executive Employment Agreement, by and between Leading BioSciences, Inc. and Michael Dawson, M.D., dated December 16, 2020 (Filed With SEC on December 23, 2020)

Executive Employment Agreement, by and between Leading BioSciences, Inc. and Thomas Hallam, Ph.D., dated December 16, 2020 (Filed With SEC on December 23, 2020)

Executive Employment Agreement, by and between Leading BioSciences, Inc. and JD Finley, dated December 16, 2020 (Filed With SEC on December 23, 2020)

Leading BioSciences, Inc. Amended and Restated 2013 Employee, Director and Consultant Equity Incentive Plan and Forms of Stock Option Grant Notice, Stock Option Agreement and... (Filed With SEC on December 23, 2020)

Agreement and Plan of Merger, dated as of December 16, 2020, by and among Seneca Biopharma, Inc., Leading BioSciences, Inc. and Townsgate Acquisition Sub 1, Inc (Filed With SEC on December 21, 2020)

Form of CVR Agreement (Filed With SEC on December 21, 2020)

Form of Bridge Warrant (Filed With SEC on December 21, 2020)

Form of Equity Warrant (Filed With SEC on December 21, 2020)

Registration Rights Agreement, by and between Seneca Biopharma, Inc. and the investor party thereto, dated December 16, 2020 (Filed With SEC on December 21, 2020)

Form of Company Support Agreement, dated as of December 16, 2020, by and between Leading BioSciences, Inc. and each of the parties named in each agreement therein (Filed With SEC on December 21, 2020)

Form of LBS Support Agreement, dated as of December 16, 2020, by and between Seneca Biopharma, Inc. and each of the parties named in each agreement therein (Filed With SEC on December 21, 2020)

Form of Company Lock-Up Agreement (Filed With SEC on December 21, 2020)

Form of LBS Lock-Up Agreement (Filed With SEC on December 21, 2020)

Securities Purchase Agreement, by and between Leading BioSciences, Inc. and the investor party thereto, dated December 16, 2020 (Filed With SEC on December 21, 2020)

Securities Purchase Agreement, by and among Seneca Biopharma, Inc., Leading BioSciences, Inc. and the investor party thereto, dated December 16, 2020 (Filed With SEC on December 21, 2020)

Form of Leak-Out Agreement, by and between Seneca Biopharma, Inc. and the investor party thereto (Filed With SEC on December 21, 2020)

Form of Placement Agent Warrant (Filed With SEC on May 27, 2020)

Form of Securities Purchase Agreement (Filed With SEC on May 27, 2020)

Employment Agreement with Dane Saglio (Filed With SEC on April 2, 2020)

Employment Agreement with Matthew Kalnik, PhD (Filed With SEC on April 2, 2020)

Inducement Stock Option Plan adopted 2/15/2016 and as amended on 12/12/2018, 9/13/2019, and 3/23/20 (Filed With SEC on March 27, 2020)

Amendment to Employment Agreement with Kenneth Carter effective April 1,2020 (Filed With SEC on March 27, 2020)

Form of Replacement Warrant (Series P) (Filed With SEC on January 22, 2020)

Form of Replacement Warrant (Series Q) (Filed With SEC on January 22, 2020)

Form of Placement Agent Warrant (Filed With SEC on January 22, 2020)

Letter Agreement dated January 17, 2020 (Filed With SEC on January 22, 2020)

Form of Placement Agent Agreement (Filed With SEC on January 22, 2020)

NEURALSTEM, INC. AMENDED AND RESTATED INDUCEMENT AWARD STOCK OPTION PLAN (Filed With SEC on November 14, 2019)

Form of Underwriting Agreement (Filed With SEC on July 24, 2019)

Form of Series M and Series N Warrant (Filed With SEC on July 24, 2019)

Form of Series O Pre-Funded Warrant (Filed With SEC on July 24, 2019)

Form of Restricted Stock Unit from 2019 Equity Incentive Plan (Filed With SEC on June 21, 2019)

Form of Stock Option Grant from 2019 Equity Incentive Plan (Filed With SEC on June 21, 2019)

Form of Restricted Stock Grant from 2019 Equity Incentive Plan (Filed With SEC on June 21, 2019)

Consultant Warrant for Hibiscus BioVentures, LLC issued January 2019 (Filed With SEC on May 14, 2019)

Inducement Stock Option Plan adopted 2/15/2016 and as amended on 12/12/2018 (Filed With SEC on March 22, 2019)

Inducement Award Stock Option Plan as amended on December 12, 2018 (Filed With SEC on December 18, 2018)

Kenneth Carter Employment Agreement (Filed With SEC on December 18, 2018)

Confidential Information and Invention Assignment Agreement (Filed With SEC on December 18, 2018)

Indemnification Agreement (Filed With SEC on December 18, 2018)

Form of Warrant (Filed With SEC on October 29, 2018)

Form of Placement Agent Warrant (Filed With SEC on October 29, 2018)

Form of Securities Purchase Agreement (Filed With SEC on October 29, 2018)

Form of Placement Agent Agreement (Filed With SEC on October 29, 2018)

Jim Scully Binding Term Sheet (Filed With SEC on August 9, 2018)

3,000,000 Shares of Common Stock and Warrants to Purchase 2,250,000 Shares of Common Stock NEURALSTEM, INC. UNDERWRITING AGREEMENT (Filed With SEC on July 28, 2017)

Neuralstem, Inc. Warrant To Purchase CommonStock (Filed With SEC on July 28, 2017)

SEPARATION AGREEMENT AND RELEASE (Filed With SEC on May 4, 2017)

Form of Inducement Warrant (Filed With SEC on March 20, 2017)

Letter Agreement for Warrant Exercises (Filed With SEC on March 20, 2017)

SCHEDULE A (Filed With SEC on November 8, 2016)

Neuralstem, Inc. A Delaware Corporation (Filed With SEC on September 12, 2016)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on September 12, 2016)

AMENDMENT TO GENERAL RELEASE AND WAIVER OFCLAIMS AGREEMENT (Filed With SEC on June 16, 2016)

COMMON STOCK PURCHASE WARRANT Neuralstem,Inc. (Filed With SEC on May 13, 2016)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on May 13, 2016)

20,000,000 Shares of Common Stock and Warrants to Purchase 20,000,000 Sharesof Common Stock NEURALSTEM, INC. UNDERWRITING AGREEMENT (Filed With SEC on May 4, 2016)

COMMON STOCK PURCHASE WARRANT NEURALSTEM,INC. (Filed With SEC on May 4, 2016)

General Release and Waiver of Claims (Filed With SEC on March 4, 2016)

NEURALSTEM, INC. INDUCEMENT AWARD STOCK OPTION PLAN (Filed With SEC on February 19, 2016)

NEURALSTEM. INC. NON-QUALIFIED STOCK OPTION AGREEMENT (Filed With SEC on February 19, 2016)

EMPLOYMENT AGREEMENT (Filed With SEC on February 19, 2016)

nEURALSTEM,INC. CONFIDENTIALINFORMATION AND INVENTION ASSIGNMENT AGREEMENT Employee Name: Richard Daly Effective Date: February 15, 2016 (Filed With SEC on February 19, 2016)

INDEMNIFICATIONAGREEMENT (Filed With SEC on November 16, 2015)

20271Goldenrod Lane, 2nd Floor | Germantown, MD 20876 ###-###-####| Fax: 301 ###-###-#### (Filed With SEC on May 11, 2015)

EMPLOYMENT AGREEMENT AMENDMENT (Filed With SEC on March 2, 2015)

WARRANT AGREEMENT WSA 00173 To Purchase Shares of Common Stock of NEURALSTEM, INC. Dated as of October 28 2014 (the “EffectiveDate”) (Filed With SEC on October 29, 2014)

SECOND AMENDMENT (Filed With SEC on October 29, 2014)

EMPLOYMENT AGREEMENT AMENDMENT (Filed With SEC on September 18, 2014)

SERIES __ COMMON STOCK PURCHASE WARRANT NEURALSTEM,INC. (Filed With SEC on January 6, 2014)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on January 6, 2014)

COMMON STOCK PURCHASE WARRANT NEURALSTEM,Inc. (Filed With SEC on November 12, 2013)

AT THE MARKET OFFERING AGREEMENT October [*],2013 (Filed With SEC on October 25, 2013)

SERIES J COMMON STOCK PURCHASE WARRANT NEURALSTEM,INC. (Filed With SEC on September 10, 2013)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on September 10, 2013)

COMMON STOCK PURCHASE WARRANT NEURALSTEM,Inc. (Filed With SEC on August 8, 2013)

WARRANT AGREEMENT WSA 00157 To Purchase Shares of Common Stock of NEURALSTEM, INC. Dated as of March 22, 2013 (the “EffectiveDate”) (Filed With SEC on March 27, 2013)

WARRANT AGREEMENT To Purchase Shares of Common Stock of NEURALSTEM, INC. Dated as of March 22, 2013 (the “EffectiveDate”) (Filed With SEC on March 27, 2013)

LOANAND SECURITY AGREEMENT (Filed With SEC on March 27, 2013)

INTELLECTUAL PROPERTY SECURITY AGREEMENT (Filed With SEC on March 27, 2013)

PLACEMENTAGENCY AGREEMENT (Filed With SEC on September 19, 2012)

Form of Placement Agent Warrant Agreement (Filed With SEC on September 19, 2012)

$2,400,000in Shares of Common Stock NEURALSTEM,INC. UNDERWRITING AGREEMENT (Filed With SEC on August 17, 2012)

Form of Representative’s Warrant Agreement (Filed With SEC on August 17, 2012)

COMMON STOCK PURCHASE WARRANT NEURALSTEM,Inc. (Filed With SEC on August 9, 2012)

EMPLOYMENT AGREEMENT RENEWAL AND AMENDMENT (Filed With SEC on July 27, 2012)

EMPLOYEE AGREEMENT RENEWAL AND AMENDMENT (Filed With SEC on July 27, 2012)

SERIES I COMMON STOCK PURCHASE WARRANT NEURALSTEM,INC. (Filed With SEC on February 8, 2012)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on February 8, 2012)

MANAGEMENT CONSULTING AGREEMENT (Filed With SEC on March 16, 2011)

NEURALSTEM,INC. CommonStock ($0.01par value per share) AT-THE-MARKET EQUITY OFFERINGSALESAGREEMENT (Filed With SEC on November 22, 2010)

NEURALSTEM,INC. 2010EQUITYCOMPENSATION PLAN (Filed With SEC on July 14, 2010)

ADDENDUMA INDEMNIFICATIONPROVISIONS (Filed With SEC on June 29, 2010)

AMENDMENT TO ENGAGEMENTAGREEMENT (Filed With SEC on June 29, 2010)

COMMONSTOCK PURCHASE WARRANT NEURALSTEM,INC. (Filed With SEC on June 29, 2010)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on June 29, 2010)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on March 31, 2010)

COMMONSTOCK PURCHASE WARRANT NEURALSTEM,INC. (Filed With SEC on March 31, 2010)

NEURALSTEM,INC. STOCKPLAN STOCKOPTION AGREEMENT (Filed With SEC on March 31, 2010)

- 2- - (Filed With SEC on July 1, 2009)

[SERIES D/E/F]COMMON STOCK PURCHASE WARRANT NEURALSTEM,INC. (Filed With SEC on July 1, 2009)

PLACEMENTAGENT WARRANT NEURALSTEM,INC. (Filed With SEC on July 1, 2009)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on July 1, 2009)

I.Richard Garr President& CEO (Filed With SEC on December 18, 2008)

COMMONSTOCK PURCHASE WARRANT NEURALSTEM,INC. (Filed With SEC on December 18, 2008)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on December 18, 2008)

Exclusive Option Agreement (Filed With SEC on February 25, 2008)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on February 25, 2008)

Registration Rights Agreement (Filed With SEC on February 25, 2008)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on March 16, 2007)

COMMON STOCK PURCHASE WARRANT NEURALSTEM, INC. Warrant Shares: _______ Initial Exercise Date: March __, 2007 (Filed With SEC on March 16, 2007)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on March 16, 2007)

Category

Industry

Companies

Contracts

Neuralstem, Inc. Contracts & Agreements